LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference

Rhea-AI Summary

LENSAR, Inc. (NASDAQ: LNSR), a leader in medical technology for cataract treatment, has announced that CEO Nick Curtis will present at the H.C. Wainwright Virtual BioConnect Conference. The presentation will be available on-demand starting January 10, 2022, at 7:00 a.m. Eastern Time, accessible through the Investors section of the company's website. LENSAR specializes in advanced femtosecond laser systems aimed at improving surgical outcomes for cataracts and corneal astigmatism, incorporating proprietary technologies for enhanced precision and efficiency.

ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer, will present at the H.C. Wainwright Virtual BioConnect Conference.

Mr. Curtis’ presentation will be available on-demand beginning at 7:00 a.m. Eastern Time on Monday, January 10, 2022 and can be accessed through the Investors section of the Company's website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220103005482/en/

Thomas R. Staab, II, CFO

ir.contact@lensar.com

Lee Roth / Cameron Radinovic

Burns McClellan for LENSAR

lroth@burnsmc.com / cradinovic@burnsmc.com

Source: LENSAR, Inc.

FAQ

When will LENSAR's CEO present at the H.C. Wainwright Virtual BioConnect Conference?

LENSAR's CEO will present on January 10, 2022, at 7:00 a.m. Eastern Time.

How can I access the LENSAR presentation from the conference?

The presentation will be available on-demand through the Investors section of LENSAR's website.

What is LENSAR's focus in medical technology?

LENSAR focuses on advanced femtosecond laser surgical solutions for treating cataracts and managing corneal astigmatism.

What technologies does LENSAR utilize in its laser systems?

LENSAR's laser systems incorporate proprietary technologies designed to enhance visual outcomes and surgical efficiency.

Where can I find more information about LENSAR?

More information about LENSAR can be found on their official website.